Select Language

Immunohistochemistry (IHC) Antibody Customization Services

Tailored for difficult targets, first-in-class targets, and companion diagnostic needs of customers, ACROBiosystems provides IHC antibody development service, solving the problem where commercial antibodies perform poorly or are unavailable for specific targets, specific indications, or specific tissue types, thereby supporting customers’ pathology research, clinical companion diagnostic (CDx) development, and biomarker detection in clinical trials. Full-process antibody customization service from immunogen design to pathology validation, ensuring high specificity, high sensitivity, and feasibility in real tissue samples.

Service Offerings

IHC Antibody Customization Service

IHC Antibody Screening service

Click Here to Inquire Now

Our Platform & Advantages

Our Platform

General Workflow

Our Advantages

Aligned with cutting-edge biologics research

Success Rate

Leveraging diverse immunization and mature screening platforms (800+ projects), our success rate reaches 60%, helping clients avoid repeated investment costs.

Validated to meet IHC clinical practices

Clinical Applicability

Early IHC screening across multiple sample types ensures antibodies perform well in clinical samples, meeting downstream clinical grade analysis needs.

Ready-to-use options for easy application

Complete Rights & Flexible Licensing

We offer full ownership of self‑developed antibodies with flexible licensing options, helping clients mitigate potential IP risks.

Consistent and stable product availability

Global Production & Supply Assurance

With 15+ years of production experience and global logistics, we provide end‑to‑end supply from development to commercial production, supporting multi‑site projects worldwide.

General Workflow

Application Cases

Example of case 1 – ROR1

Use polypeptide as immunogen, ACRO developed ROR1 IHC antibody for biopharma and use in the clinical stage. The staining data on human colorectal cancer FFPE sample was demonstrated below as an example, showing positive staining with no background.

Human Colorectal Cancer (FFPE) – 20x

Example of Case 2 – CCR8

Use mRNA as immunogen, ACRO developed CCR8 IHC antibody with complete rights. The staining data on human breast cancer FFPE sample was demonstrated below as an example, showing positive staining with no background.

Human Breast Cancer (FFPE) – 20x

Example of Case 3 – PTK7

Use ACRO protein as immunogen, we developed PTK7 IHC antibody with complete rights. The staining data on human cervical cancer FFPE sample was demonstrated below as an example, showing positive staining with no background.

Human Cervical Cancer – 20x